FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows EFFECT and supplements the active offering with updated prospectus details.
2026-01-06 · 0001493152-26-000503
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows F-1/A and marks the registration effective.
2025-12-31 · 9999999995-26-000007
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
2025-12-05 · 0001493152-25-026376
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
2025-10-08 · 0001493152-25-017407
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
2025-09-03 · 0001641172-25-026342
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-05-19 · 0001641172-25-011431
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-05-06 · 0001641172-25-008789
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-04-17 · 0001641172-25-005218
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2025-03-28 · 0001641172-25-001024
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Kepler Group Ltd, a Cayman Islands holding company, is preparing for its initial public offering (IPO) of ordinary shares, with the proceeds intended to fund operations through its Hong Kong-based subsidiaries. The offering is structured through the Cayman holding company rather than the operating subsidiaries, introducing unique risks related to regulatory scrutiny in China and Hong Kong, including potential restrictions on fund transfers and compliance with U.S. securities laws like the HFCA Act. The company emphasizes its reliance on dividends from subsidiaries and highlights uncertainties around regulatory changes and listing approvals.
2024-12-06 · 0001493152-24-049094